Further research is needed to investigate the potential causal links between GLP-1RAs and PI through other underlying mechanisms
Use when : Patient is on maintenance therapy like antihypertensive, diabetes meds, or antidepressants
Supportive strategies: Prioritize nutrient-rich, minimally processed meals (veg, fruits, whole grains, legumes, lean proteins, nuts, seeds) and fluids so that the foundation of their diet is nutritionally adequate
2025 Mar;125(3):408-421
The American Hospital Associations Coding Clinic for ICD-10-CM/PCS remains the authoritative source for clarification on ambiguous coding scenarios and is regularly updated to address evolving payer questions
10 in stock (can be backordered) Tirzepatide is a dual GIP/GLP-1 receptor agonist (twincretin) developed by Eli Lilly and approved by the FDA in 2022 for type 2 diabetes (Mounjaro) and in 2023 for obesity (Zepbound)